Portugal’s Cannabis Exports Triple: 42 Tonnes to Germany and Growing as Europe’s Processing Hub

How did a small Atlantic nation become the EU’s dominant cannabis processing hub, and what do Portugal’s cannabis laws mean for operators, investors, and the broader European supply chain?

Portugal shipped 55,164 kg of medical cannabis to Germany in 2025 â�� up from 17,230 kg in 2024, a 220% year-over-year increase. In the first three quarters alone, 42,076 kg had already crossed the border, making Portugal the second-largest supplier to Europe’s biggest medical cannabis market, trailing only Canada’s 93,006 kg. These are not modest gains for a country that only legalized medical cannabis cultivation in 2018.

The numbers tell a broader story. Portugal’s total cannabis exports surged 172% to 32,558 kg in 2024, and by August 2025 the country had already surpassed that full-year figure. With 125 authorized medicinal cannabis companies, 25 EU-GMP certified facilities, and a regulatory framework purpose-built for pharmaceutical-grade export, Portugal has cemented itself as Europe’s cannabis processing hub â�� a gateway between global cultivation and the continent’s rapidly expanding patient markets.

But Portugal’s cannabis landscape is far more complex than export tonnage suggests. The same country that decriminalized all drugs in 2001 still has no legal recreational market, no cannabis cafes, and no dispensaries selling THC products over the counter. For European operators, supply chain managers, and investors watching this market, understanding both the industrial export machine and the on-the-ground reality of weed in Portugal is essential to making informed decisions.

Portugal’s Cannabis Laws: Decriminalization, Medical Access, and What Remains Illegal

To understand Portugal’s position in the global cannabis trade, you first need to understand portugal cannabis laws â�� a framework that is frequently mischaracterized by international media.

The 2001 Decriminalization Model

In July 2001, Portugal became the first country in Europe to decriminalize the personal use and possession of all drugs, including cannabis. Under Law 30/2000, possession of up to a 10-day personal supply � defined as 25 grams of cannabis flower or 5 grams of hashish � is not a criminal offence. Instead, individuals found in possession are referred to a local Commission for the Dissuasion of Drug Addiction (Comissao para a Dissuasao da Toxicodependencia), which may impose administrative sanctions such as fines, community service, or treatment referrals.

This distinction is critical: decriminalization is not legalization. The buying, selling, trafficking, and large-scale cultivation of cannabis remain criminal offences under Portuguese law. The penalty for drug trafficking can reach 12 years in prison for significant quantities.

Health Outcomes of Decriminalization

Portugal’s approach has produced measurable public health results over 25 years:

These outcomes have made Portugal a model for harm-reduction advocates globally, but they have not translated into legalization of recreational cannabis sales or consumption venues.

Medical Cannabis Legalization (2018)

Medical cannabis was legalized in Portugal in June 2018 under Decree-Law 8/2019, establishing the regulatory framework administered by INFARMED (the National Authority for Medicines and Health Products). Patients with qualifying conditions can obtain cannabis-based medicines through licensed pharmacies with a prescription from a registered physician.

However, domestic patient access remains extremely limited. Portugal’s estimated medical cannabis sales in 2025 were valued at just over EUR 280,000 â�� a fraction of the country’s export revenue. The paradox is striking: Portugal grows and processes tonnes of pharmaceutical-grade cannabis for German patients while its own citizens struggle to access the same products through the domestic healthcare system.

Weed in Portugal: What the Law Actually Means on the Ground

The phrase "weed in portugal" returns millions of search results, most from tourists trying to understand what they can and cannot do. Here is the practical reality.

Personal Possession

Carrying up to 25 grams of cannabis flower or 5 grams of hashish is a civil infraction, not a crime. Police may confiscate the substance and refer the individual to a dissuasion commission, but there is no arrest, no criminal record, and typically no fine for first-time or infrequent users. Repeat referrals can result in administrative sanctions.

Purchasing and Selling

Buying and selling cannabis remains illegal. There is no legal retail channel for recreational THC cannabis in Portugal. Street transactions carry legal risk for both parties � and in tourist areas, the risk of scams or counterfeit products is significant.

Home Cultivation

Growing cannabis plants at home for personal use exists in a legal grey area. While small-scale cultivation (a few plants) is unlikely to result in criminal prosecution under the decriminalization framework, it is technically not authorized by Portuguese law. Commercial cultivation without an INFARMED licence is a criminal offence.

CBD Products

CBD products derived from hemp with THC content below 0.2% are legal and widely available in shops across Portugal. CBD oils, capsules, and topicals can be purchased without a prescription. However, CBD-infused food products remain restricted under EU Novel Food regulations, and any product marketed with health claims must comply with European food safety directives.

Cannabis Cafes Portugal: The Current Status of Social Consumption

Visitors searching for "cannabis cafes portugal" expecting an Amsterdam-style experience will be disappointed. There are no legal cannabis cafes, coffee shops, or social consumption venues in Portugal.

Historical Context

Unlike the Netherlands, which has tolerated cannabis coffee shops since the 1970s under a formal gedoogbeleid (tolerance policy), Portugal has never established a legal framework for social cannabis consumption. Traditional cannabis-style cafes were effectively banned in 2013 through enforcement actions.

Cannabis Social Clubs

Spain’s cannabis social club model â�� where private, membership-based clubs cultivate and distribute cannabis to members â�� has no legal equivalent in Portugal. While informal cannabis associations exist, they operate without regulatory recognition or legal protection. Access typically requires local residency and personal referrals, making them inaccessible to tourists and foreign operators.

Advocacy for Reform

Portuguese cannabis advocacy organizations continue to campaign for the creation of regulated social clubs, arguing they would provide a safer consumption environment and reduce black market activity. As of April 2026, no legislative proposal has advanced to create such a framework, though the conversation has intensified as neighbouring Spain’s club model continues to operate and Germany’s cannabis clubs launched in 2024.

Portugal Weed Shops: The Pharmacy Model and CBD Retail

When people search for "portugal weed shops," they are typically looking for one of two things: legal access to medical cannabis or CBD retail locations. Here is what exists.

Medical Cannabis: Pharmacy-Only Access

Medical cannabis in Portugal is dispensed exclusively through licensed pharmacies with a valid physician prescription. There are no dedicated cannabis dispensaries, no walk-in clinics prescribing cannabis, and no online ordering platforms for THC products. The pharmacy model means that medical cannabis is treated identically to other controlled pharmaceutical products.

Qualifying conditions include chronic pain, epilepsy, multiple sclerosis, nausea from chemotherapy, and other conditions where conventional treatments have proven inadequate. The prescribing physician must be registered with INFARMED.

CBD Shops and Hemp Retail

Legal CBD and hemp product shops operate throughout Portugal’s major cities, particularly in Lisbon and Porto. These establishments sell:

• CBD oils and tinctures (THC below 0.2%)
• Hemp flower for aromatherapy (non-smokable labelling)
• CBD cosmetics and topicals
• Hemp-derived edibles (within EU Novel Food compliance)

Notable retail locations include the Cannabis Store Amsterdam chain (which, despite its name, sells only legal CBD products) and various independent CBD boutiques in tourist areas. Portugal even has a 24/7 CBD vending machine operated by Canapuff in Lisbon.

What You Cannot Buy

THC cannabis flower, concentrates, or edibles cannot be purchased from any retail establishment in Portugal without a medical prescription. Any shop claiming to sell THC products is operating illegally.

Weed in Lisbon: The Capital’s Cannabis Landscape

Lisbon is the centre of Portugal’s cannabis ecosystem â�� both the regulated pharmaceutical industry and the informal consumer scene. Understanding the capital gives operators and investors a ground-level view of the market.

The Regulated Side

Lisbon and its surrounding districts host several major cannabis companies, including RPK Biopharma (owned by Holigen/Flowr, located in the Lisbon district) and multiple EU-GMP certified processing facilities. The city is also home to INFARMED’s headquarters, making it the regulatory nerve centre for Portugal’s entire medicinal cannabis framework.

The Portugal Medical Cannabis Conference (PTMC), held annually in Lisbon, has become one of Europe’s premier industry events, attracting operators, regulators, and investors from across the continent.

The Consumer Reality

For consumers, weed in Lisbon operates in a grey zone shaped by decriminalization. The neighbourhoods of Bairro Alto, Alfama, and Santa Catarina have historically had more cannabis-visible atmospheres, though this reflects tolerance rather than legality. Hash is significantly more prevalent than flower in the informal market, reflecting Portugal’s proximity to North African supply routes.

CBD shops cluster in tourist-heavy areas of Baixa and Chiado, offering the only legal retail cannabis experience available to visitors. Private cannabis associations exist but require local connections and do not advertise publicly.

Key Fact for Operators

Lisbon’s real significance is not its consumer market â�� it is the business infrastructure. The city offers direct flights to every major European capital, a skilled pharmaceutical workforce, competitive operating costs compared to Northern Europe, and proximity to INFARMED’s regulatory apparatus. These factors explain why international cannabis companies consistently choose the Lisbon metropolitan area for their European headquarters.

Portugal’s Export Machine: The Numbers Behind Europe’s Cannabis Hub

Portugal’s transformation into Europe’s cannabis processing hub has been rapid and data-driven. Here are the figures that define the market.

Export Volume Growth (2020-2025)

The acceleration in 2024-2025 is dramatic. Portugal went from exporting fewer than 5 tonnes in 2020 to over 55 tonnes to a single market â�� Germany â�� by 2025. This trajectory has positioned Portugal as the world’s second-largest cannabis exporter behind Canada.

Where Portuguese Cannabis Goes

Germany is the dominant destination, but Portugal serves multiple European markets:

The Processing Hub Model

Portugal’s export success is not solely built on domestic cultivation. The country functions increasingly as a processing and re-exportation hub:

1. Bulk cannabis is imported � predominantly from Canada, but also from Colombia, Thailand, and other GACP-certified origins
2. Portuguese EU-GMP certified contract manufacturing organizations (CMOs) process, decontaminate, test, and repackage the material
3. Finished pharmaceutical-grade products are exported into European patient markets under EU-GMP certification

This model has earned Portuguese CMOs the informal designation of "GMP washers" � facilities that add the EU-GMP compliance layer required for European market access. While the term carries some controversy, it reflects a legitimate and valuable role in the global cannabis supply chain: converting GACP-grade bulk material into products that meet the stringent requirements of European regulators.

INFARMED Licensing: The Regulatory Framework Powering Exports

Portugal’s cannabis industry operates under a licensing framework administered by INFARMED that is both comprehensive and, as of 2025, increasingly demanding.

License Categories and Fees

Companies may hold multiple licence types simultaneously. As of October 2025, the broader authorized landscape included 38 cultivation companies, 26 manufacturing companies, 162 import-authorized entities, 158 export-authorized entities, and 258 wholesale distribution authorizations � reflecting the rapid growth in companies seeking to participate in the supply chain.

Quality Standards Required

• GACP (Good Agricultural and Collection Practices): Mandatory for cultivation â�� covers growing environments, pesticide management, harvest documentation, and seed-to-harvest traceability
• EU-GMP (Good Manufacturing Practices): Required for manufacturing and export â�� the prerequisite for selling into Germany and other regulated European markets
• GDP (Good Distribution Practices): Governs storage, transport, and wholesale operations

2025 Regulatory Tightening

INFARMED significantly tightened its oversight in 2025, driven partly by Operation Erva Daninha ("Operation Weed") � a major enforcement action involving over 70 search warrants that targeted criminal organizations allegedly using licensed companies to falsify export documentation.

Key changes include:

• Extended approval timelines: Export permit processing stretched from under six weeks to 70+ days in some cases
• New documentation requirements: Scan-verifiable EU-GMP or PIC/S GMP certificates required for every import/export authorization
• Stability data requirements: INFARMED now reviews product-specific stability data including storage and transport condition simulations
• Planning buffer: Operators must now build 8-12 week planning buffers into supply chain operations
• Digital transformation: INFARMED announced plans to digitize its licensing and authorization processes, a move that could significantly streamline operations once implemented

License Removals

In a sign of increasing enforcement rigour, INFARMED removed licences from several companies in late 2025 and early 2026, including Cannacare in March 2026. Analysts note this reflects the regulator’s commitment to maintaining the integrity of Portugal’s pharmaceutical cannabis framework.

Major Portuguese Cannabis Companies

Portugal’s cannabis industry is anchored by a mix of international operators and homegrown companies, many of which have achieved EU-GMP certification.

Key Players

Tilray Portugal â�� Located in the Coimbra district, Tilray’s Portuguese facility is part of the company’s global cultivation network spanning Germany, Portugal, and the United Kingdom. Tilray reported record international cannabis revenue growth of 36% in Q2 Fiscal 2026, with Portugal playing a key supply role.

RPK Biopharma â�� Based in the Lisbon district and owned by Holigen (a Flowr subsidiary), RPK Biopharma holds cultivation and manufacturing licences and has been one of Portugal’s earliest and most established cannabis operators.

Curaleaf Portugal (formerly Clever Leaves Portugal) � Operating from approximately 110,000 square feet of greenhouse facilities on a 9-million-square-foot land parcel, this facility was acquired by Curaleaf as part of its European expansion strategy. It holds EU-GMP certification.

SOMAI Pharmaceuticals â�� Acquired RPK Biopharma’s assets and won EU-GMP certification for its Portuguese facility, positioning itself as a vertically integrated European cannabis pharmaceutical company.

LEF/Infosaude â�� Portugal’s leading GMP analysis laboratory, providing analytical services, pre-formulation studies, and product development support. LEF’s team of over 70 scientists and regulatory experts serves the majority of the Portuguese cannabis market and holds EU-GMP certification.

EU-GMP Certified Companies

As of 2025, approximately 25 companies in Portugal hold EU-GMP certification, including Agrivabe, Batherafarm, Cannprisma, Curaleaf Portugal, GBE Pharma, Infosaude, Labialfarma, MHI Cultivo Medicinal (Medicane), Portocanna, and RPK Biopharma, among others. This concentration of certified facilities is a core competitive advantage and a key reason global cannabis companies choose Portugal as their European processing base.

Portugal Weed: Market Outlook and Challenges for 2026-2027

The broader picture of portugal weed � from industrial export to consumer market to investment landscape � faces both significant opportunity and mounting challenges.

Opportunities

• Germany’s market continues to expand: Germany imported 201,094 kg of medical cannabis in 2025, nearly tripling 2024’s 72,706 kg. With an import limit increase of 70 tonnes recently approved, demand shows no sign of slowing
• New European markets opening: Poland, Malta, Czech Republic, and the UK are all expanding patient access, creating new export destinations for Portuguese producers
• Processing hub advantage: Portugal’s EU-GMP infrastructure and regulatory track record give it a structural advantage in converting global bulk supply into European-compliant finished products
• Market projected to grow: Portugal’s cannabis market is forecast to grow at 2.23% CAGR through 2029, with medical and pharmaceutical segments growing at 4-5% CAGR

Challenges

• INFARMED bottlenecks: Extended permit processing times (70+ days) and new documentation requirements are creating supply chain delays that frustrate exporters
• Competition from Spain: Spain is actively positioning itself as an alternative European processing hub, with its own climate advantages and a larger domestic market
• Price compression: As global cannabis production scales, wholesale prices are falling â�� Portugal’s operators must compete on efficiency, not just volume
• Domestic market neglect: With barely EUR 280,000 in domestic medical sales, Portugal risks being seen as a processing colony for Northern European markets rather than a complete cannabis economy
• Regulatory enforcement risk: Operation Erva Daninha demonstrated that Portugal’s regulators will act decisively against non-compliance, creating uncertainty for operators with marginal compliance practices

How GrowerIQ Supports Cannabis Operations in Portugal and the EU Export Market

For cannabis companies operating in Portugal � whether cultivating, processing, or re-exporting � the regulatory environment demands end-to-end traceability, EU-GMP compliance documentation, and seamless integration with laboratory testing. This is exactly the infrastructure GrowerIQ provides.

EU-GMP Compliance and Documentation

GrowerIQ’s seed-to-sale platform generates the complete documentation trail that INFARMED and European regulators require: batch records, environmental monitoring logs, processing documentation, and export authorization data. With INFARMED’s 2025 tightening of documentation requirements â�� including scan-verifiable GMP certificates and product-specific stability data â�� having an automated, audit-ready system is no longer optional.

Export Tracking and Supply Chain Management

For companies shipping to Germany, Poland, the UK, and other European markets, GrowerIQ tracks every lot from cultivation through final export shipment. This includes:

• Lot-level traceability from seed or clone through harvest, processing, packaging, and export
• Multi-destination inventory management â�� critical for companies serving multiple European markets with different regulatory requirements
• Export documentation generation aligned with INFARMED’s updated 2025 requirements
• Recall readiness across multiple jurisdictions and export destinations

Partnership with LEF/Infosaude

GrowerIQ’s partnership with LEF/Infosaude â�� Portugal’s leading GMP analysis laboratory â�� integrates laboratory testing results directly into the seed-to-sale platform. This partnership delivers:

• Seamless traceability linking production records to analytical results
• Online documentation for regulatory submissions and audit preparation
• Access to LEF’s team of 70+ scientists and regulatory experts trusted by the majority of Portugal’s cannabis market
• Pre-formulation and product development support for companies developing EU-GMP compliant products

This partnership is particularly valuable for international companies entering the Portuguese market, providing both the software infrastructure and the scientific expertise needed to meet INFARMED’s standards from day one.

GACP and EU-GMP Workflow Integration

GrowerIQ supports the full quality management chain � from GACP-compliant cultivation records through EU-GMP manufacturing documentation to GDP-compliant distribution tracking. For companies operating as CMOs or vertically integrated producers, this unified platform eliminates the data silos that create compliance gaps.

Frequently Asked Questions

Is weed legal in Portugal?

Cannabis is decriminalized in Portugal, not legalized. Since 2001, possession of up to 25 grams of flower or 5 grams of hashish for personal use is a civil infraction � not a criminal offence. However, buying, selling, and cultivating cannabis without a licence remain illegal. Medical cannabis is legal with a prescription since 2018, dispensed through pharmacies.

Can I buy cannabis in a shop in Portugal?

You cannot buy THC cannabis from any retail shop in Portugal without a medical prescription. CBD products (THC below 0.2%) are available in shops throughout major cities. Medical cannabis requires a physician’s prescription and is dispensed only through licensed pharmacies.

Are there cannabis cafes in Portugal?

No. There are no legal cannabis cafes, coffee shops, or social consumption venues in Portugal. Cannabis social clubs, which operate in a grey area in Spain, have no legal framework in Portugal.

Why is Portugal exporting so much cannabis if it’s not fully legal?

Portugal’s cannabis exports operate under a completely separate regulatory framework from its consumer drug policy. INFARMED licenses companies for pharmaceutical-grade cultivation, manufacturing, and export under strict EU-GMP standards. These products are destined for medical markets in Germany and other countries â�� not for recreational sale in Portugal.

How does Portugal compare to the Netherlands for cannabis?

The Netherlands tolerates recreational cannabis sales through its coffee shop system but has a more limited pharmaceutical export industry. Portugal takes the opposite approach: strict prohibition of recreational sales and consumption venues, combined with a large-scale pharmaceutical export infrastructure. For cannabis businesses, Portugal offers production and processing opportunities; for consumers, the Netherlands offers a more permissive environment.

This article is current as of April 2026 and reflects export data through full-year 2025, INFARMED licensing data through March 2025, and regulatory developments through Q1 2026. For official licensing information, consult INFARMED directly. For information on how GrowerIQ supports cannabis operations in Portugal and across Europe, visit our LEF/Infosaude partnership page.

Sources:

• German Medical Cannabis Imports Hit Record Highs â�� StratCann
• Germany Imported Over 201 Tonnes of Medical Cannabis in 2025 â�� International CBC
• Portugal Cannabis Exports Have Nearly Tripled â�� International CBC
• Portugal Cannabis Exports Almost Triple â�� The Portugal News
• Portugal Medical Cannabis Market 2025 â�� Prohibition Partners
• Portugal to Become the New El Dorado of Medical Cannabis in Europe â�� Fortune
• INFARMED Grants Eight New Licenses â�� CannaReporter
• Iberian Peninsula Faces Strategic Challenges as Cannabis Hub â�� CannaReporter
• Portugal 2025: INFARMED Tightens Import/Export â�� Cannabis Regulations AI
• Transatlantic Triangle Under Pressure â�� CannaMonitor
• Global Cannabis Trade in 2025 â�� StratCann
• GrowerIQ Partnership with LEF/Infosaude
• Drug Policy of Portugal â�� Wikipedia
• Cannabis in Portugal â�� Wikipedia
• Cannabis Law and Legislation in Portugal â�� CMS Expert Guides "},"caller":{"type":"direct"}}],"stop_reason":"tool_use